Biomarkers, Pharmacological
-
Subject Areas on Research
- A network-heuristic approach to improve the impact of genomic data on drug discovery.
- A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.
- Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer.
- Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation.
- Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population.
- Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update.
- Genetic characterization to improve interpretation and clinical management of hepatotoxicity caused by tyrosine kinase inhibitors.
- Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions.
- Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.
- Guidelines for the welfare and use of animals in cancer research.
- Individualizing pharmacogenomic test results in the context of the microbiome.
- Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs.
- Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.
- Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment.
- Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer.
- Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: importance of achieving treatment-free remission.
- Not ready for prime time.
- Reply to M A Khattak et al.
- Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.
- Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin.
- Statistical methods for assessment of biosimilarity using biomarker data.
- Therapeutic implications of biomarkers in chronic heart failure.
- Three dimensional dose distribution comparison of simple and complex acquisition trajectories in dedicated breast CT.
- Translational platelet research in patients with coronary artery disease: what are the major knowledge gaps?
-
Keywords of People
- Guan, Ziqiang, Research Professor in Biochemistry, Biochemistry
- Halabi, Susan, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
- Hanks, Brent A., Associate Professor of Medicine, Pharmacology & Cancer Biology
- O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology
- Sullivan, Daniel Carl, Professor Emeritus of Radiology, Radiology
- Yi, John S, Adjunct Assistant Professor in the Department of Surgery, Surgery, Surgical Sciences
- Young, Ken H, Professor of Pathology, Pathology